The global SARS-CoV-2 pandemic prompted rapid development of COVID-19 vaccines.
Although several vaccines have received emergency approval through various public health …

The coronavirus disease 2019 (COVID-19) pandemic, caused by infection with the severe
acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is having a deleterious impact on …

The ongoing COVID-19 pandemic, caused by infection with SARS-CoV-2, is having a
dramatic and deleterious impact on health services and the global economy. Grim public …

Abstract The coronavirus disease 2019 (COVID-19) pandemic continues to spread globally,
highlighting the urgent need for safe and effective vaccines that could be rapidly mobilized …

A mouse model of SARS-CoV-2 that can be developed in any molecular biology lab with
standard facilities will be valuable in evaluating drugs and vaccines. Here we present a …

Despite mass public health efforts, the SARS-CoV2 pandemic continues as of late 2021 with
resurgent case numbers in many parts of the world. The emergence of SARS-CoV2 variants …

Hybrid immunity (vaccination+ natural infection) to SARS-CoV-2 provides superior
protection to re-infection. We performed immune profiling studies during breakthrough …

The outbreak of the SARS-CoV-2 virus and its rapid spread into a global pandemic made
the urgent development of scalable vaccines to prevent coronavirus disease (COVID-19) a …

More than a year after emergence of the SARS-CoV-2 pandemic, multiple first-generation
vaccines are approved and available for vaccination. Still, many challenges remain. The …

Several COVID-19 vaccines, some more efficacious than others, are now available and
deployed, including multiple mRNA-and viral vector-based vaccines. With the focus on …